Arax Advisory Partners’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
13,899
+11,441
+465% +$88.4K ﹤0.01% 2449
2026
Q1
$17.9K Buy
2,458
+2,433
+9,732% +$16.9K ﹤0.01% 2141
2025
Q4
$176 Sell
25
-10,545
-100% -$63.6K ﹤0.01% 3743
2025
Q3
$58.1K Buy
+10,570
New +$51.8K ﹤0.01% 1758
2025
Q2
Sell
-248
Closed -$1.65K 3136
2025
Q1
$1.65K Buy
248
+156
+170% +$1.19K ﹤0.01% 2129
2024
Q4
$679 Sell
92
-65
-41% -$466 ﹤0.01% 2257
2024
Q3
$1.1K Hold
157
﹤0.01% 2218
2024
Q2
$771 Buy
+157
New +$947 ﹤0.01% 2245

Other funds holding LFST

Arax Advisory Partners's LFST Position: Q2 2026 in Review

Arax Advisory Partners increased its Lifestance Health (LFST) stake by 465% in Q2 2026, buying an estimated $88.4K and bringing the position to 13,899 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Arax Advisory Partners first reported a position in LFST in Q2 2024 and has held it in 8 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Arax Advisory Partners held 13,899 shares of Lifestance Health worth $149K as of Q2 2026.
  • Arax Advisory Partners bought 11,441 Lifestance Health shares in Q2 2026, an estimated $88.4K.
  • Lifestance Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2449 holding.
  • Arax Advisory Partners first reported a position in Lifestance Health in Q2 2024 and has held it in 8 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.